• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

爱沙尼亚帕金森病的患病率。

Prevalence of Parkinson's disease in Estonia.

作者信息

Taba Pille, Asser Toomas

机构信息

Department of Neurology and Neurosurgery, University of Tartu, Tartu, Estonia.

出版信息

Acta Neurol Scand. 2002 Nov;106(5):276-81. doi: 10.1034/j.1600-0404.2002.01286.x.

DOI:10.1034/j.1600-0404.2002.01286.x
PMID:12371921
Abstract

OBJECTIVES

To investigate the prevalence of idiopathic Parkinson's disease (PD) in Tartu district of South Estonia, with a population of 153,240 on prevalence day, 1 January 1996.

METHODS

The community-based method of case ascertainment was used, followed by neurologic examination.

RESULTS

The age-adjusted prevalence was 152 per 100,000 population, 159 for urban and 139 for the rural group, 154 for men and 153 for women. The age-specific prevalence increased from 22 per 100,000 population in the age group 40-49 years up to 1232 per 100,000 population in the age group 70-79 years. The mean age of PD patients was 71.4 years, the mean age at onset of the symptoms - 66.9 years.

CONCLUSIONS

When comparing the prevalence rates with other studies of Caucasian populations in Europe, the results are similar except for slightly but not significantly higher prevalence rates in the urban population in Estonia.

摘要

目的

调查1996年1月1日患病率调查当日爱沙尼亚南部塔尔图地区特发性帕金森病(PD)的患病率,该地区当时人口为153,240人。

方法

采用基于社区的病例确诊方法,随后进行神经学检查。

结果

年龄调整后的患病率为每10万人中有152例,城市组为159例,农村组为139例,男性为154例,女性为153例。年龄特异性患病率从40 - 49岁年龄组的每10万人22例增加到70 - 79岁年龄组的每10万人1232例。帕金森病患者的平均年龄为71.4岁,症状出现时的平均年龄为66.9岁。

结论

与欧洲其他白种人群体的研究相比,患病率结果相似,只是爱沙尼亚城市人口的患病率略高但无显著差异。

相似文献

1
Prevalence of Parkinson's disease in Estonia.爱沙尼亚帕金森病的患病率。
Acta Neurol Scand. 2002 Nov;106(5):276-81. doi: 10.1034/j.1600-0404.2002.01286.x.
2
Incidence of Parkinson's disease in estonia.爱沙尼亚帕金森病的发病率。
Neuroepidemiology. 2003 Jan-Feb;22(1):41-5. doi: 10.1159/000067105.
3
The increasing prevalence of Parkinson's disease in Estonia.爱沙尼亚帕金森病的发病率不断上升。
Acta Neurol Scand. 2018 Sep;138(3):251-258. doi: 10.1111/ane.12948. Epub 2018 Apr 29.
4
Different prevalence rates of Parkinson's disease in urban and rural areas: a population-based study in Taiwan.城乡帕金森病患病率的差异:台湾一项基于人群的研究。
Neuroepidemiology. 2009;33(4):350-7. doi: 10.1159/000254572. Epub 2009 Nov 4.
5
A national registry to determine the distribution and prevalence of Parkinson's disease in Thailand: implications of urbanization and pesticides as risk factors for Parkinson's disease.一个用于确定泰国帕金森病分布和流行情况的全国性登记处:城市化和农药作为帕金森病危险因素的影响。
Neuroepidemiology. 2011;37(3-4):222-30. doi: 10.1159/000334440. Epub 2011 Dec 1.
6
Changing epidemiology of Parkinson's disease in southwestern Finland.芬兰西南部帕金森病流行病学的变化
Neurology. 1999 Jan 15;52(2):302-8. doi: 10.1212/wnl.52.2.302.
7
Epidemiology of Parkinson's disease in Finland.芬兰帕金森病的流行病学
Acta Neurol Scand. 1976 Feb;53(2):81-102. doi: 10.1111/j.1600-0404.1976.tb04328.x.
8
The epidemiology of Parkinson's disease in the county of Rogaland, Norway.挪威罗加兰郡帕金森病的流行病学情况。
Mov Disord. 1995 Sep;10(5):541-9. doi: 10.1002/mds.870100503.
9
Epidemiological study and clinical profile of Parkinson's disease in the Assiut Governorate, Egypt: a community-based study.埃及阿西尤特省的帕金森病的流行病学研究和临床特征:一项基于社区的研究。
Neuroepidemiology. 2012;38(3):154-63. doi: 10.1159/000335701. Epub 2012 Mar 29.
10
Prevalence of Parkinson's disease and related disorders in the elderly population of greater Beijing, China.中国北京地区老年人群中帕金森病及相关疾病的患病率。
Mov Disord. 2003 Jul;18(7):764-72. doi: 10.1002/mds.10445.

引用本文的文献

1
The Regional Burden of Parkinson's Disease in Kazakhstan 2014-2021: Insights From National Health Data.2014 - 2021年哈萨克斯坦帕金森病的区域负担:来自国家健康数据的洞察
Parkinsons Dis. 2025 May 1;2025:4317554. doi: 10.1155/padi/4317554. eCollection 2025.
2
Trends in parkinson's disease mortality in China from 2004 to 2021: a joinpoint analysis.中国帕金森病死亡率趋势分析(2004 年至 2021 年):联合分析
BMC Public Health. 2024 Apr 19;24(1):1091. doi: 10.1186/s12889-024-18532-8.
3
The Current State of Parkinsonism in West Africa: A Systematic Review.
西非帕金森综合征的现状:一项系统综述
Parkinsons Dis. 2021 Sep 30;2021:7479423. doi: 10.1155/2021/7479423. eCollection 2021.
4
Clinical Profile of Parkinson's Disease: Experience of Niger.帕金森病的临床概况:尼日利亚的经验
J Neurosci Rural Pract. 2018 Apr-Jun;9(2):214-218. doi: 10.4103/jnrp.jnrp_337_17.
5
Does Botulinum neurotoxin type A treatment for sialorrhea change oral health?A型肉毒杆菌神经毒素治疗流涎症会改变口腔健康状况吗?
Clin Oral Investig. 2017 Apr;21(3):795-800. doi: 10.1007/s00784-016-1826-z. Epub 2016 Apr 26.
6
Systematic review of the prevalence and incidence of Parkinson's disease in Asia.亚洲帕金森病患病率和发病率的系统评价。
J Epidemiol. 2009;19(6):281-93. doi: 10.2188/jea.je20081034. Epub 2009 Oct 3.
7
The co-occurrence of early onset Parkinson disease and 22q11.2 deletion syndrome.早发性帕金森病与22q11.2缺失综合征的共现。
Am J Med Genet A. 2009 Mar;149A(3):525-8. doi: 10.1002/ajmg.a.32650.
8
Validation of an Estonian version of the Parkinson's Disease Questionnaire (PDQ-39).爱沙尼亚语版帕金森病问卷(PDQ - 39)的验证
Health Qual Life Outcomes. 2008 Mar 25;6:23. doi: 10.1186/1477-7525-6-23.